NCT02622139View on ClinicalTrials.gov

Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD)

NACompletedINTERVENTIONAL

Enrollment

344

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

October 31, 2017

Study Completion Date

December 31, 2019

Conditions

Crohn's DiseaseUlcerative ColitisIBD

Interventions

DEVICE

Multispectral Optoacoustic Tomography (MSOT)

MSOT for the evaluation of disease activity in IBD patients

Trial Locations (1)

91054

Medical Department 1, University of Erlangen-Nürnberg, Erlangen

All Listed Sponsors

collaborator

iThera Medical GmbH

INDUSTRY

lead

University of Erlangen-Nürnberg Medical School

OTHER

NCT02622139 - Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD) | Biotech Hunter | Biotech Hunter